STOCK TITAN

Lazard Asset Management Reports 10.1M Shares of DENTSPLY SIRONA (5.1%)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Lazard Asset Management LLC filed a Schedule 13G reporting ownership of 10,107,657 shares of DENTSPLY SIRONA Inc. (CUSIP 24906P109), representing 5.1% of the outstanding equity as of 06/30/2025. The filer reports sole voting power over 10,002,455 shares and sole dispositive power over 10,107,657 shares. The filing identifies the reporting person as an investment adviser (IA) organized in New York and includes a certification that the securities are not held to change or influence control of the issuer. The filing is signed by Mark Anderson, Managing Director, General Counsel, dated 08/14/2025.

Positive

  • Material disclosure: Ownership exceeds 5% (10,107,657 shares), meeting SEC thresholds for investor visibility
  • Clear control attributes: Reporting of sole voting (10,002,455) and sole dispositive power (10,107,657) clarifies internal authority over the position
  • Filing classification: Submitted under Schedule 13G as an investment adviser (IA), indicating passive intent rather than a control-seeking acquisition
  • Certification provided: Explicit statement that shares are not held to change or influence control of the issuer

Negative

  • None.

Insights

TL;DR: Lazard Asset Management now holds a material 5.1% stake in DENTSPLY SIRONA, indicating meaningful passive institutional ownership.

The Schedule 13G shows Lazard as an investment adviser with 10.1 million shares (5.1%), reporting sole voting and dispositive power over the majority of its stake. Because this is a 13G (not 13D) and the filing includes a certification that the position is not intended to influence control, the disclosure signals a sizable, likely passive, institutional position rather than an activist stake. Investors should note the exact voting and dispositive counts which confirm centralized portfolio control within Lazard.

TL;DR: A >5% disclosure via Schedule 13G highlights material ownership but affirms no intent to seek control, consistent with passive investor behavior.

The filer’s classification as an investment adviser and the explicit certification against seeking control align with Schedule 13G filing norms for passive investors. The limited shared voting/dispositive power (reported at zero) suggests internal centralized decision-making at Lazard for these shares. From a governance perspective, a single institutional holder at this level can still influence outcomes through routine engagement, though this filing does not indicate activist intentions.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Lazard Asset Management LLC
Signature:Mark Anderson
Name/Title:Managing Director, General Counsel
Date:08/14/2025

FAQ

What percentage of DENTSPLY SIRONA (XRAY) does Lazard Asset Management own?

The filing reports 10,107,657 shares, representing 5.1% of the class as of 06/30/2025.

Does Lazard Asset Management have voting control over its XRAY shares?

Yes. The filer reports sole voting power over 10,002,455 shares and sole dispositive power over 10,107,657 shares.

Is this filing a Schedule 13G or 13D and what does that imply?

This is a Schedule 13G filed by an investment adviser (IA), which typically indicates a passive investment with no intent to change or influence control.

When was the Schedule 13G signed and who signed it?

The filing is signed by Mark Anderson, Managing Director, General Counsel, dated 08/14/2025.

Where is Lazard Asset Management organized and where is the issuer located?

Lazard Asset Management LLC is organized in New York; DENTSPLY SIRONA's principal executive offices are listed in Charlotte, North Carolina.